Who
Edward M. Basile
Director
Company insider
Files Form 4 as: Director, TransMedics Group.
In numbers
- Trades disclosed
- 49
- Buys
- 1
- Sells
- 11
- Bought
- $136K
- Sold
- $6.3M
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 6 May 2019
- Last trade
- 20 May 2026
- Last filed
- 22 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 May 2026filed 22 May 2026 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code A | —2,922 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code A | —2,922 at $0.00 | filing |
| 29 Oct 2025filed 31 Oct 2025 | TMDX TransMedics Groupoption or derivative · Medical Devices | SEC FORM 4 Code M | —4,142 | filing |
| 29 Oct 2025filed 31 Oct 2025 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code M | $2,8994,142 at $0.70 | filing |
| 29 Oct 2025filed 31 Oct 2025 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Sold | $540K4,142 at $130.45 | filing |
| 4 Aug 2025filed 5 Aug 2025 | TMDX TransMedics Groupoption or derivative · Medical Devices | SEC FORM 4 Code M | —4,143 | filing |
| 4 Aug 2025filed 5 Aug 2025 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code M | $2,9004,143 at $0.70 | filing |
| 4 Aug 2025filed 5 Aug 2025 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Sold | $520K4,143 at $125.51 | filing |
| 27 May 2025filed 29 May 2025 | TMDX TransMedics Groupoption or derivative · Medical Devices | SEC FORM 4 Code M | —5,000 | filing |
| 27 May 2025filed 29 May 2025 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code M | $3,5005,000 at $0.70 | filing |
| 27 May 2025filed 29 May 2025 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Sold | $632K5,000 at $126.45 | filing |
| 22 May 2025filed 23 May 2025 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code A | —2,134 at $0.00 | filing |
| 9 May 2025filed 13 May 2025 | TMDX TransMedics Groupoption or derivative · Medical Devices | SEC FORM 4 Code M | —6,000 | filing |
| 9 May 2025filed 13 May 2025 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code M | $4,2006,000 at $0.70 | filing |
| 9 May 2025filed 13 May 2025 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Sold | $694K6,000 at $115.63 | filing |
| 5 Nov 2024filed 7 Nov 2024 | TMDX TransMedics Groupoption or derivative · Medical Devices | SEC FORM 4 Code M | —6,750 at $0.00 | filing |
| 5 Nov 2024filed 7 Nov 2024 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code M | $190K6,750 at $28.12 | filing |
| 5 Nov 2024filed 7 Nov 2024 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Sold | $441K5,296 at $83.35 | filing |
| 5 Nov 2024filed 7 Nov 2024 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Sold | $123K1,454 at $84.30 | filing |
| 6 Aug 2024filed 8 Aug 2024 | TMDX TransMedics Groupoption or derivative · Medical Devices | SEC FORM 4 Code M | —6,750 at $0.00 | filing |
News
TransMedics Group (NASDAQ:TMDX) and Cerus (NASDAQ:CERS) Head-To-Head ContrastTMDX · themarketsdaily.com · 13 Oct 2026TransMedics Group (NASDAQ:TMDX) Research Coverage Started at BarclaysTMDX · themarketsdaily.com · 10 Oct 2026
0 headlines in the last 90 days name Edward M. Basile; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.